Clinical Ink adds mobile medical device connectivity to its clinical trial platform
The solution was developed with cooperation from Qualcomm Life, Novartis and PPD, which are also supporting a pilot clinical study before broad commercial use.
Clinical Ink, CentrosHealth merge to create a world-class clinical trial technology platform
Clinical Ink has also entered into a strategic partnership with Novartis Pharmaceuticals, as part of their Trials of the Future initiative.